Dr. Phyllis Owusu-Griffin, MD

Dr. Owusu-Griffin practices at Baystate Medical Practices, Inc in West Springfield, Massachusetts.

Dr. Owusu-Griffin's NPI, 1427251438, was assigned on June 7, 2007. Dr. Owusu-Griffin holds Massachusetts license 244654.

Dr. Owusu-Griffin's primary practice is Baystate Medical Practices, Inc, at 46 Daggett Dr, West Springfield, MA 01089 in Hampden County. The practice phone is (413) 794-5700.

Dr. Owusu-Griffin's primary practice is Baystate Medical Practices, Inc in West Springfield, Massachusetts. Dr. Owusu-Griffin is also affiliated with Baystate Medical Center. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Owusu-Griffin to 3 more hospitals, 3 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Owusu-Griffin practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Owusu-Griffin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Owusu-Griffin is licensed in Massachusetts.

CMS data shows 925 Medicare services from Dr. Owusu-Griffin across 12 procedure codes in 2024, for 294 Medicare patients. Medicare paid $59,942 for them. Every service was in an office.

CMS counts 294 Medicare patients who saw Dr. Owusu-Griffin in 2024. The largest group is 65 to 74, with 135 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Owusu-Griffin's median patient age at 65, with 57% women.

In 2024, Dr. Owusu-Griffin wrote 8,148 Medicare Part D claims for 622 patients. 85% of them were for generic drugs. CMS names the drug for 7,448 of them, across 124 drugs with 11 or more claims each, at $664,478 in total drug cost. In 2023, CMS named 7,210 claims across 123 drugs.

Dr. Owusu-Griffin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Owusu-Griffin as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Owusu-Griffin from 5 drug and device companies from 2017 to 2023. Education make up the largest share, 67% of the total. Abbott Laboratories paid the most, $123.